Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Investigation|June 1, 2026
Cancer stem cells synthesize proline to attenuate oxidative stressWeichi Wu, Po Zhang, Donghai Wang, et al.Scientific Reports|October 14, 2022
Bee-safe peptidomimetic acaricides achieved by comparative genomicsVikas Jindal, Daqi Li, Leslie C Rault, et al.The Lancet. Haematology|March 26, 2021
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialLu Sun, Juan Wang, Linlin Shao, et al.Nature Communications|March 22, 2018
The genomic and functional landscapes of developmental plasticity in the American cockroachSheng Li, Shiming Zhu, Qiangqiang Jia, et al.Cell Reports|June 3, 2026
HSPA6 maintains IMPDH2 phosphorylation to regulate GTP synthesis for driving radioresistance of glioblastoma stem cellsJunlei Yang, Qiankun Lin, Danling Gu, et al.Nature Communications|June 6, 2026
IQGAP3 bridges matrix stiffness with glioma stem cell maintenance and radioresistance by stabilizing SOX2Po Zhang, Weichi Wu, Tengfei Huang, et al.Neuro-Oncology|June 7, 2025
Nuclear cholesterol regulates nuclear size and DNA damage responses in cancer stem cellsTingting Duan, Suchet Taori, Shruti Bhargava, et al.Haematologica|January 18, 2024
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumorsYuqin Song, Junning Cao, Qingyuan Zhang, et al.American Journal of Hematology|September 2, 2020
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trialYafei Yu, Miaomiao Wang, Yu Hou, et al.Nature Cell Biology|January 6, 2026
Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastomaDaqi Li, Gaoyuan Cui, Kailin Yang, et al.Pageof 7